Table 2.
Clinical and pathologic characteristics of patients with BC stratified by AFR in the whole cohort
| Characteristics | AFR | P value | |
|---|---|---|---|
| ≤12.21 | >12.21 | ||
| Number of patients, n (%) | 86 (24.0) | 272 (76.0) | |
| Age (year), n (%) | <0.001* | ||
| ≤65 | 18 (20.9) | 131 (48.2) | |
| >65 | 68 (79.1) | 141 (51.8) | |
| Gender, n (%) | 0.183 | ||
| Male | 61 (70.9) | 212 (77.9) | |
| Female | 25 (29.1) | 60 (22.1) | |
| BMI category, n (%) | 0.251 | ||
| Normal | 40 (46.5) | 142 (52.2) | |
| Thin | 5 (5.8) | 5 (1.8) | |
| Overweight | 34 (39.5) | 105 (38.6) | |
| Obesity | 7 (8.1) | 20 (7.4) | |
| Diabetes, n (%) | 0.412 | ||
| No | 70 (81.4) | 210 (77.2) | |
| Yes | 16 (18.6) | 62 (22.8) | |
| Smoking status, n (%) | 0.480 | ||
| Never | 52 (60.5) | 165 (60.7) | |
| Ex-smoker | 6 (7.0) | 30 (11.0) | |
| Current | 28 (32.6) | 77 (28.3) | |
| T stage, n (%) | 0.019* | ||
| Ta | 43 (50.0) | 174 (64.0) | |
| T1 | 27 (31.4) | 77 (28.3) | |
| T2 | 10 (11.6) | 14 (5.1) | |
| T3+T4 | 6 (7.0) | 7 (2.6) | |
| Tumor grade, n (%) | 0.037* | ||
| Low | 31 (36.0) | 133 (48.9) | |
| High | 55 (64.0) | 139 (51.1) | |
| Concomitant CIS, n (%) | 0.492 | ||
| No | 82 (95.3) | 264 (97.1) | |
| Yes | 4 (4.7) | 8 (2.9) | |
| Tumor multifocality, n (%) | 0.574 | ||
| No | 47 (54.7) | 158 (58.1) | |
| Yes | 39 (45.3) | 114 (41.9) | |
| Operation, n (%) | 0.006* | ||
| TURBT | 75 (87.2) | 260 (95.6) | |
| RC | 11 (12.8) | 12 (4.4) | |
| Chemotherapy immediately after operation, n (%) | 0.007* | ||
| No | 19 (22.1) | 29 (10.7) | |
| Yes | 67 (77.9) | 243 (89.3) | |
| Glb (g/L), Median (IQR) | 31.2 (8.0) | 29.2 (5.8) | <0.001* |
| CHOL (mg/dL), Median (IQR) | 168.0 (44.0) | 176.9 (52.3) | 0.003* |
| HDL (mg/dL), Median (IQR) | 42.5 (11.6) | 42.5 (15.5) | 0.282 |
| LDL (mg/dL), Median (IQR) | 96.7 (35.8) | 104.4 (42.5) | 0.002* |
| Hb (g/L), Mean ± SD | 129.4 ± 21.3 | 141.8 ± 17.4 | <0.001* |
| PLT (109/L), Mean ± SD | 211.4 ± 64.4 | 211.2 ± 54.0 | 0.984 |
Note: *P value<0.05.
Abbreviations: BC: bladder cancer; AFR: albumin-to-fibrinogen ratio; BMI: body mass index; CIS: carcinoma in situ; TURBT: transurethral resection of bladder tumor; RC: radical cystectomy; Glb: globulin; CHOL: cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; Hb: hemoglobin; PLT: blood platelet.